On April 13, 2023, Dialogue Health Technologies Inc., a Canadian virtual healthcare platform, finalized an acquisition deal for London-based Tictrac Ltd., a SaaS provider of health and wellness platforms, with a transaction value of up to $56 million CAD, contingent on specific conditions and customary adjustments. The transaction, which is expected to close within 30 days, will be funded through cash and common shares. Dialogue will pay $24 million CAD in cash at closing, and the remaining $32 million CAD is tied to revenue milestones, payable partly in cash and common shares. The deal represents Dialogue's largest acquisition, aimed at enhancing its Integrated Health Platform™ by incorporating Tictrac's wellness services and international market reach. The acquisition rationale highlighted the opportunity to extend care, increase the total addressable market, drive user engagement, add a scalable SaaS model, and improve financial growth with Tictrac's high-margin product contributing to Dialogue's profitability. Tictrac's expected annual recurring revenue is approximately $13 million CAD by the end of 2022. The transaction carries an implied forward valuation of 3.9x ARR by the end of the earn-out period effective March 31, 2023. Dialogue's legal counsel was McCarthy Tétrault LLP, while Tictrac was advised by finnCap Cavendish financially and Armstrong Teasdale LLP legally.